Medivir AB: Marketing Authorization Application for Lipsovir(R) Submitted to European Regulatory Authorities

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir (STO:MVIRB) has now submitted an application for marketing authorization to the European regulatory authorities for LipsovirĀ®, a topical product for prevention and treatment of cold sores.

Back to news